Association of pvl gene with incomplete hemolytic phenotype in clinical Staphylococcus aureus

References

• Cribier B, Prevost G, Couppie P, Finck-Barbançon V, Grosshans E, Piémont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology. 1992;185:175–180. doi:10.1159/0002474431446082
   PubMed Web of Science ®Google Scholar
• Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–1132. doi:10.1086/31346110524952
   PubMed Web of Science ®Google Scholar
• Diep BA, Gillet Y, Etienne J, Lina G, Vandenesch F. Panton-Valentine leucocidin and pneumonia. Lancet Infect Dis. 2013;13:566. doi:10.1016/S1473-3099(13)70102-6
   Web of Science ®Google Scholar
• Prevost G, Cribier B, Couppie P, et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun. 1995;63:4121–4129.7558328
   PubMed Web of Science ®Google Scholar
• Woodin AM. Fractionation of a leucocidin from Staphylococcus aureus. Biochem J. 1959;73:225–237. doi:10.1042/bj073022513845859
   PubMed Web of Science ®Google Scholar
• Pedelacq JD, Maveyraud L, Prevost G, et al. The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure. 1999;7:277–287.10368297
   PubMed Web of Science ®Google Scholar
• Finck-Barbancon V, Duportail G, Meunier O, Colin DA. Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta. 1993;1182:275–282.8399361
   PubMed Web of Science ®Google Scholar
• Gladstone GP, Van Heyningen WE. Staphylococcal leucocidins. Br J Exp Pathol. 1957;38:123–137.13426414
   PubMed Web of Science ®Google Scholar
• Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A. 2010;107:5587–5592. doi:10.1073/pnas.091240310720231457
   PubMed Web of Science ®Google Scholar
• Hongo I, Baba T, Oishi K, Morimoto Y, Ito T, Hiramatsu K. Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin. J Infect Dis. 2009;200:715–723. doi:10.1086/60533219653829
   PubMed Web of Science ®Google Scholar
• Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661. doi:10.1128/CMR.00134-1426016486
   PubMed Web of Science ®Google Scholar
• Kreienbuehl L, Charbonney E, Eggimann P. Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care. 2011;1:52. doi:10.1186/2110-5820-1-5222192614
   PubMed Web of Science ®Google Scholar
• Flammier S, Rasigade JP, Badiou C, et al. Human monocyte-derived osteoclasts are targeted by Staphylococcal pore-forming toxins and superantigens. PLoS One. 2016;11:e0150693. doi:10.1371/journal.pone.015069326934588
   PubMed Web of Science ®Google Scholar
• Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:43–54. doi:10.1016/S1473-3099(12)70238-423103172
   PubMed Web of Science ®Google Scholar
• Xia G, Wolz C. Phages of Staphylococcus aureus and their impact on host evolution. Infect Genet Evol. 2014;21:593–601. doi:10.1016/j.meegid.2013.04.02223660485
   PubMed Web of Science ®Google Scholar
• Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest. 2007;87:3–9. doi:10.1038/labinvest.370050117146447
   PubMed Web of Science ®Google Scholar
• Klein S, Menz MD, Zanger P, Heeg K, Nurjadi D. Increase in the prevalence of Panton-Valentine leukocidin and clonal shift in community-onset methicillin-resistant Staphylococcus aureus causing skin and soft-tissue infections in the Rhine-Neckar Region, Germany, 2012-2016. Int J Antimicrob Agents. 2019;53:261–267. doi:10.1016/j.ijantimicag.2018.10.02630412736
   PubMed Web of Science ®Google Scholar
• David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616–687. doi:10.1128/CMR.00081-0920610826
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978–984. doi:10.3201/eid0908.03008912967497
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Taneike I, Mimura D, et al. Gene sequences and specific detection for Panton-Valentine leukocidin. Biochem Biophys Res Commun. 2005;328:995–1002. doi:10.1016/j.bbrc.2005.01.05415707976
   PubMed Web of Science ®Google Scholar
• Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Jama. 2003;290:2976–2984. doi:10.1001/jama.290.22.297614665659
   PubMed Web of Science ®Google Scholar
• Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis. 2006;194:1761–1770. doi:10.1086/50950617109350
   PubMed Web of Science ®Google Scholar
• Zhang H, Zheng Y, Gao H, et al. Identification and characterization of Staphylococcus aureus strains with an incomplete hemolytic phenotype. Front Cell Infect Microbiol. 2016;6:146. doi:10.3389/fcimb.2016.0014627917374
   PubMed Web of Science ®Google Scholar
• Saha B, Harlan DM, Lee KP, June CH, Abe R. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med. 1996;183:2675–2680. doi:10.1084/jem.183.6.26758676089
   PubMed Web of Science ®Google Scholar
• Thomas D, Chou S, Dauwalder O, Lina G. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy. 2007;93:24–41. doi:10.1159/00010085617369698
   PubMedGoogle Scholar
• Song KH, Kim ES, Park KH, et al. Clinical and molecular characterization of panton-valentine leukocidin-positive invasive Staphylococcus aureus infections in Korea. Microb Drug Resist. 2019;25:450–456. doi:10.1089/mdr.2018.023830379606
   PubMed Web of Science ®Google Scholar
• McClure JA, Conly JM, Lau V, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J Clin Microbiol. 2006;44:1141–1144. doi:10.1128/JCM.44.3.1141-1144.200616517915
   PubMed Web of Science ®Google Scholar
• Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother. 2007;51:2765–2773. doi:10.1128/AAC.01513-0617517843
   PubMed Web of Science ®Google Scholar
• Fenton M, Keary R, McAuliffe O, Ross RP, O’Mahony J, Coffey A. Bacteriophage-derived peptidase CHAP(K) eliminates and prevents Staphylococcal biofilms. Int J Microbiol. 2013;2013:625341. doi:10.1155/2013/62534123431312
   PubMedGoogle Scholar
• O’Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol. 2005;71:1836–1842. doi:10.1128/AEM.71.4.1836-1842.200515812009
   PubMed Web of Science ®Google Scholar